Phosphatidylethanol as an outcome measure in treatment aimed at controlled drinking.

Autor: Hammarberg A; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Norra Stationsgatan 69, 7th Floor, 113 64 Stockholm, Sweden., Ingesson Hammarberg S; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Norra Stationsgatan 69, 7th Floor, 113 64 Stockholm, Sweden., Redegren Cuellar S; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Norra Stationsgatan 69, 7th Floor, 113 64 Stockholm, Sweden., Guterstam J; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Norra Stationsgatan 69, 7th Floor, 113 64 Stockholm, Sweden.

Publikováno v: Alcohol and alcoholism (Oxford, Oxfordshire) [Alcohol Alcohol] 2024 Sep 21; Vol. 59 (6).

A multicomponent LC-MS/MS method for drugs of abuse testing using volumetric DBS and a clinical evaluation by comparison with urine.

Autor: Guterstam J; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden., Tavic C; ABCLabs AB, Solna, Sweden., Barosso M; ABCLabs AB, Solna, Sweden., Beck O; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden; ABCLabs AB, Solna, Sweden. Electronic address: olof.beck@ki.se.

Publikováno v: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Jun 15; Vol. 243, pp. 116075. Date of Electronic Publication: 2024 Mar 03.

The risk and development of work disability among individuals with gambling disorder: a longitudinal case-cohort study in Sweden.

Autor: Månsson V; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.; Division of Psychiatry, Health Care Dalarna, Region of Dalarna, Sweden., Pettersson E; Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Mittendorfer-Rutz E; Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Guterstam J; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden., Berman AH; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.; Department of Psychology, Uppsala University, Uppsala, Sweden., Jayaram-Lindström N; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden., Molero Y; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Psychological medicine [Psychol Med] 2024 May; Vol. 54 (7), pp. 1391-1402. Date of Electronic Publication: 2023 Nov 20.

Toward a European Standard of Training in Addiction Medicine and Psychology.

Autor: Guterstam J; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, and Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

Publikováno v: European addiction research [Eur Addict Res] 2024; Vol. 30 (3), pp. 138-139. Date of Electronic Publication: 2024 Feb 16.

A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS.

Autor: Metrebian N; National Addiction Centre, King's College London, London, UK., Carter B; Biostatistics and Health Informatics, King's College London, London, UK., Eide D; National Addiction Centre, King's College London, London, UK.; Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway., McDonald R; National Addiction Centre, King's College London, London, UK.; Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway., Neale J; National Addiction Centre, King's College London, London, UK., Parkin S; National Addiction Centre, King's College London, London, UK., Dascal T; National Addiction Centre, King's College London, London, UK., Mackie C; National Addiction Centre, King's College London, London, UK., Day E; Birmingham & Solihull Mental Health NHS Foundation Trust, Birmingham, UK., Guterstam J; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden., Horsburgh K; Scottish Drugs Forum, Glasgow, Scotland, UK., Kåberg M; Stockholm Centre for Dependency Disorders, Stockholm, Sweden.; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden., Kelleher M; South London and Maudsley NHS Foundation Trust, London, UK., Smith J; Public Health Wales, Cardiff, Wales, UK., Thiesen H; Sundheds Team, City of Copenhagen, Denmark., Strang J; National Addiction Centre, King's College London, London, UK. John.strang@kcl.ac.uk.; South London and Maudsley NHS Foundation Trust, London, UK. John.strang@kcl.ac.uk.

Publikováno v: BMC public health [BMC Public Health] 2023 Aug 24; Vol. 23 (1), pp. 1608. Date of Electronic Publication: 2023 Aug 24.